Objective : to assess the benefits of using contrast-enhancer spectral mammography in patients with an established category BI-RADS 4a, 4b according results a standard examination (digital and ultrasound). Materials methods . The date 425 suspicious period from 2018 2021 were analyzed. As part additional examination, all underwent contrast-enhanced follow by histological verification identified...